selected publications
-
academic article
- Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma.. Journal of immunotherapy (Hagerstown, Md. : 1997). 31:72-80. 2008